Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2020 1
2021 7
2022 3
2023 2
2024 6
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Protective mucosal SARS-CoV-2 antibodies in the majority of the general population in the Netherlands.
Verheul MK, Kaczorowska J, Hofstee MI, Schepp RM, Smits GP, Wessels Beljaars D, Kuijer M, Schuin W, Middelhof I, Wong D, van Hagen CCE, Vos ERA, Nicolaie MA, de Melker HE, van Binnendijk RS, van der Klis FRM, den Hartog G. Verheul MK, et al. Among authors: vos era. Mucosal Immunol. 2024 Aug;17(4):554-564. doi: 10.1016/j.mucimm.2024.03.008. Epub 2024 Mar 27. Mucosal Immunol. 2024. PMID: 38553008 Free article.
Using SARS-CoV-2 nucleoprotein antibodies to detect (re)infection.
Hoeve CE, Neppelenbroek N, Vos ERA, Huiberts AJ, Andeweg SP, den Hartog G, van Binnendijk R, de Melker H, van den Hof S, Knol M. Hoeve CE, et al. Among authors: vos era. Epidemiol Infect. 2025 Feb 7;153:e38. doi: 10.1017/S095026882500010X. Epidemiol Infect. 2025. PMID: 39915267 Free PMC article.
A literature review and evidence-based evaluation of the Dutch national immunisation schedule yield possibilities for improvements.
Pluijmaekers AJM, Steens A, Houweling H, Rots NY, Benschop KSM, van Binnendijk RS, Bodewes R, Brouwer JGM, Buisman A, Duizer E, van Els CACM, Hament JM, den Hartog G, Kaaijk P, Kerkhof K, King AJ, van der Klis FRM, Korthals Altes H, van der Maas NAT, van Meijeren DL, Middeldorp M, Rijnbende-Geraerts SD, Sanders EAM, Veldhuijzen IK, Vlaanderen E, Voordouw ACG, Vos ERA, de Wit J, Woudenberg T, van Vliet JA, de Melker HE. Pluijmaekers AJM, et al. Among authors: vos era. Vaccine X. 2024 Sep 26;20:100556. doi: 10.1016/j.jvacx.2024.100556. eCollection 2024 Oct. Vaccine X. 2024. PMID: 39444596 Free PMC article. Review.
Exposure, infection and disease with the tick-borne pathogen Borrelia miyamotoi in the Netherlands and Sweden, 2007-2019.
Hoornstra D, Stukolova OA, van Eck JA, Sokolova MI, Platonov AE, Hofhuis A, Vos ERA, Reimerink JH, van den Berg OE, van den Wijngaard CC, Lager M, Wilhelmsson P, Lindgren PE, Forsberg P, Henningsson AJ, Hovius JW. Hoornstra D, et al. Among authors: vos era. J Infect. 2024 Dec;89(6):106326. doi: 10.1016/j.jinf.2024.106326. Epub 2024 Oct 23. J Infect. 2024. PMID: 39454832 Free article.
SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA or vector-based vaccination in the general Dutch population show distinct kinetics.
van den Hoogen LL, Verheul MK, Vos ERA, van Hagen CCE, van Boven M, Wong D, Wijmenga-Monsuur AJ, Smits G, Kuijer M, van Rooijen D, Bogaard-van Maurik M, Zutt I, van Vliet J, Wolf J, van der Klis FRM, de Melker HE, van Binnendijk RS, den Hartog G. van den Hoogen LL, et al. Among authors: vos era. Sci Rep. 2022 Apr 8;12(1):5935. doi: 10.1038/s41598-022-10020-6. Sci Rep. 2022. PMID: 35396570 Free PMC article.
Age-specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands.
de Boer PT, van de Kassteele J, Vos ERA, van Asten L, Dongelmans DA, van Gageldonk-Lafeber AB, den Hartog G, Hofhuis A, van der Klis F, de Lange DW, Stoeldraijer L; RIVM COVID‐19 epidemiology and surveillance team; de Melker HE, Geubbels E, van den Hof S, Wallinga J. de Boer PT, et al. Among authors: vos era. Influenza Other Respir Viruses. 2023 Aug 22;17(8):e13174. doi: 10.1111/irv.13174. eCollection 2023 Aug. Influenza Other Respir Viruses. 2023. PMID: 37621921 Free PMC article.
Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?
van den Hoogen LL, Smits G, van Hagen CCE, Wong D, Vos ERA, van Boven M, de Melker HE, van Vliet J, Kuijer M, Woudstra L, Wijmenga-Monsuur AJ, GeurtsvanKessel CH, Stoof SP, Reukers D, Wijsman LA, Meijer A, Reusken CBEM, Rots NY, van der Klis FRM, van Binnendijk RS, den Hartog G. van den Hoogen LL, et al. Among authors: vos era. Vaccine. 2022 Apr 1;40(15):2251-2257. doi: 10.1016/j.vaccine.2022.03.009. Epub 2022 Mar 9. Vaccine. 2022. PMID: 35287986 Free PMC article.
20 results